💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Aethlon Medical up 33% ahead of 60 Minutes report of CTE in combat veterans

Published 01/04/2018, 12:05 PM
© Reuters.  Aethlon Medical up 33% ahead of 60 Minutes report of CTE in combat veterans
AEMD
-
  • Nano cap Aethlon Medical (AEMD +33.3%) spikes on modestly higher volume in apparent response to an upcoming segment of 60 Minutes (Sunday, Jan. 7) about the same degenerative brain disease in soldiers returning from combat as former football players.
  • The disorder, chronic traumatic encephalopathy (CTE), was found in 110 of 111 brains of deceased NFL players in a study conducted at Boston University.
  • It appears that soldiers endure similar brain trauma from bomb blasts in combat.
  • The company is the majority stockholder in Exosome Sciences which discovered a biomarker called TauSome that can potentially be used to detect CTE in living persons.
  • Now read: HTG Molecular sees big increase in Q4 revenues and expects strong growth in 2018; shares up 27% premarket


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.